Evidence map›Paper›PMID 41618020›Full record

ArticleFamilial cancer2026

Hearing preservation and restoration surgery in NF2-related schwannomatosis.

Christopher G Wood, Nathan Huey, Christine Carter, Nathaniel Truong, Fred G Ii Barker, Scott R Plotkin, D Bradley Welling

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher G WoodDepartment of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Nathan HueyDepartment of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Christine CarterDepartment of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Nathaniel TruongDepartment of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Fred G Ii BarkerHarvard Medical School, Boston, MA, USA.
Scott R PlotkinHarvard Medical School, Boston, MA, USA.
D Bradley WellingDepartment of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, MA, USA. brad_welling@meei.harvard.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To analyze factors associated with hearing preservation in patients undergoing surgery with NF2-related schwannomatosis (NF2-SWN) vestibular schwannomas (VS), and to evaluate artificial intelligence/machine learning (AI/ML) predictors of hearing preservation. Retrospective analysis of NF2-SWN patients with a preoperative word recognition score (WRS) of greater than 50% who were undergoing surgical resection of VS with the goal of hearing preservation. Factors evaluated for influence on hearing preservation included preoperative tumor size and location, pure tone average and WRS, age of onset of NF2-SWN symptoms, auditory brainstem response (ABR), NF2 genetic severity score, inflammation in the cochlea and labyrinth, and surgical approach. The relationship between factors and hearing preservation was evaluated with univariate and multivariable analysis and a “SuperLearner” AI/ML model. When hearing was not preserved, outcomes of cochlear implants (CI) and auditory brainstem implants (ABI) are presented. Of 322 patients with NF2-SWN, 191 underwent surgical excision of VS. Fifty-two (27%) had WRS > 50% and tumor configuration allowing attempted hearing preservation. Twenty-three of the 52 patients had postoperative WRS > 50% (44%). The mean tumor size when hearing was preserved was 16.4 mm whereas the mean tumor size in those not preserved was 22.2 mm giving an odds ratio (OR) on univariate analysis of 0.90 (CI 0.85–0.95) suggesting larger tumors were less likely to have preserved hearing. For 12 patients with greater than 5-year follow up and preserved hearing, the mean time for their WRS to degrade below 50% was 11.6 years. Univariate regression also identified the presence of normal wave V on ABR having higher OR of hearing preservation 30.9 (95% CI, 3.78, 252.2) whereas tumors touching the brainstem lowered the odds ratio of hearing preservation of 0.07 (95%CI, 0.02, 0.24). However, none of the factors remained significant on multivariate regression after adjusting for other factors. In an AI/ML SuperLearner model, the most influential variables were normal ABR, lack of tumor contact with the brainstem, and preoperative WRS. The accuracy was 85% (79–91%); the sensitivity: 0.69 (0.50–0.86) and the specificity: 0.87 (0.80–0.95). This model of implies that collectively there is indeed useful information for predicting hearing preservation at surgery from these data. Cochlear implant and auditory brainstem implant rehabilitation is also reported. Seventy-three percent of NF2-SWN patients in this study had poor hearing at the time of surgery limiting hearing preservation. Current hearing preservation options are largely inadequate. Factors influencing postoperative hearing in NF2-SWN VS resection when combined with AI/ML may aid in predicting surgical outcomes. Further confirmational studies are needed. CI and ABI are shown to provide long-term hearing rehabilitation options for a modest proportion of NF2-SWN patients. Earlier intervention and better treatment options are needed.

Indexed as

Hearing LossNeurilemmomaNeurofibromatosesNeurofibromatosis 2Neuroma, AcousticSkin NeoplasmsAdolescentAdultAuditory AcuityAuditory Brain Stem ImplantationCochlear ImplantsEvoked Potentials, Auditory, Brain StemFemaleHumansMachine LearningMaleAcoustic neuroma (AN)Artificial intelligence (AI)Hearing preservationMachine learning (ML)Neurofibromatosis type 2NF2-related schwannomatosis (NF2-SWN)Surgical outcomesVestibular schwannoma (VS)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.